Sano blog | rare disease (12)

biomarkers precision medicine rare disease

Unravelling the complexities of genomics-driven drug discovery [whitepaper]

Genomics-based drug discovery offers great potential for the development of targeted therapies that can offer new and better treatment options for patients. By ...

data privacy rare disease genetic testing

The promising power and ethical considerations of newborn sequencing (inspired by the World Orphan Drug Congress USA)

Recently, our team was honoured to attend the World Orphan Drug Congress USA in Boston. The event brought together key stakeholders, experts, and industry leade...

patient recruitment rare disease

Webinar recap: How can applying a "rare disease mindset" accelerate and de-risk precision medicine trials?

In a this webinar, Patrick Short, CEO and co-founder of Sano Genetics, and Patti Engel, CEO of Engage Health, discussed how applying a “rare disease mindset” ca...

press precision medicine rare disease

Sano Genetics raises $11M in funding to accelerate genetic disease research

Sano raises $11 million in Series A funding round led by MMC Ventures New funding will support the team to grow and further its mission to accelerate personalis...

Clinical research blog

Unravelling the complexities of genomics-driven drug discovery [whitepaper]

The promising power and ethical considerations of newborn sequencing (inspired by the World Orphan Drug Congress USA)

Webinar recap: How can applying a "rare disease mindset" accelerate and de-risk precision medicine trials?

Sano Genetics raises $11M in funding to accelerate genetic disease research

Join the email list